Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
TYK Medicines, Inc. Class H ( (HK:2410) ) just unveiled an announcement.
TYK Medicines, Inc, a company incorporated in the People’s Republic of China, has announced a board meeting scheduled for March 27, 2025. The meeting will focus on approving the annual results for the year ending December 31, 2024, and considering the payment of a final dividend, impacting stakeholders by potentially influencing the company’s financial strategies and shareholder returns.
More about TYK Medicines, Inc. Class H
YTD Price Performance: -39.34%
Average Trading Volume: 423,809
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: HK$10.47B
See more insights into 2410 stock on TipRanks’ Stock Analysis page.